Zai Lab Ltd (ZLAB)
26.67
-3.27
(-10.92%)
USD |
NASDAQ |
Nov 14, 16:00
26.50
-0.17
(-0.64%)
After-Hours: 18:16
Zai Lab Enterprise Value: 2.423B for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 2.423B |
| November 12, 2024 | 2.325B |
| November 11, 2024 | 2.537B |
| November 08, 2024 | 2.490B |
| November 07, 2024 | 2.509B |
| November 06, 2024 | 2.458B |
| November 05, 2024 | 2.520B |
| November 04, 2024 | 2.517B |
| November 01, 2024 | 2.474B |
| October 31, 2024 | 2.450B |
| October 30, 2024 | 2.512B |
| October 29, 2024 | 2.571B |
| October 28, 2024 | 2.682B |
| October 25, 2024 | 2.665B |
| October 24, 2024 | 2.745B |
| October 23, 2024 | 2.323B |
| October 22, 2024 | 2.311B |
| October 21, 2024 | 2.229B |
| October 18, 2024 | 2.178B |
| October 17, 2024 | 2.066B |
| October 16, 2024 | 2.047B |
| October 15, 2024 | 1.910B |
| October 14, 2024 | 1.903B |
| October 11, 2024 | 1.963B |
| October 10, 2024 | 1.963B |
| Date | Value |
|---|---|
| October 09, 2024 | 1.895B |
| October 08, 2024 | 1.915B |
| October 07, 2024 | 2.065B |
| October 04, 2024 | 2.066B |
| October 03, 2024 | 1.893B |
| October 02, 2024 | 1.991B |
| October 01, 2024 | 1.917B |
| September 30, 2024 | 1.845B |
| September 27, 2024 | 1.794B |
| September 26, 2024 | 1.691B |
| September 25, 2024 | 1.466B |
| September 24, 2024 | 1.589B |
| September 23, 2024 | 1.504B |
| September 20, 2024 | 1.617B |
| September 19, 2024 | 1.541B |
| September 18, 2024 | 1.554B |
| September 17, 2024 | 1.509B |
| September 16, 2024 | 1.500B |
| September 13, 2024 | 1.483B |
| September 12, 2024 | 1.493B |
| September 11, 2024 | 1.589B |
| September 10, 2024 | 1.462B |
| September 09, 2024 | 1.428B |
| September 06, 2024 | 1.417B |
| September 05, 2024 | 1.397B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-55.47M
Minimum
Nov 22 2019
16.07B
Maximum
Jun 01 2021
3.879B
Average
2.066B
Median
Oct 04 2024
Enterprise Value Benchmarks
| Concord Medical Services Holdings Ltd | 1.001B |
| WuXi Biologics (Cayman) Inc | 7.772B |
| Sinovac Biotech Ltd | -6.942B |
| CASI Pharmaceuticals Inc | 91.55M |
| Adagene Inc | 29.78M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -80.28M |
| Revenue (Quarterly) | 100.50M |
| Total Expenses (Quarterly) | 176.03M |
| EPS Diluted (Quarterly) | -0.80 |
| Gross Profit Margin (Quarterly) | 64.94% |
| Profit Margin (Quarterly) | -79.87% |
| Earnings Yield | -11.25% |
| Normalized Earnings Yield | -11.64 |